This site is intended for UK Healthcare Professionals only

Licensing

molnupiravir tablets 1280x720.jpg

First oral antiviral for Covid-19 approved by MHRA

Molnupiravir reduces risk of hospitalisation or death for at-risk adults with mild to moderate Covid-19 by 50 per cent.

04 Nov 2021

Change privacy settings